Brigatinib
About
Therapy type: Targeted therapy
Therapy strategy: ALK inhibition
Mappings
NCI Thesaurus: Brigatinib (ncit:C98831)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy.| Type | Biomarker(s) | Cancer type | Therapy(ies) | |
|---|---|---|---|---|
| Sensitivity (+) | v::ALK | Non-Small Cell Lung Cancer | Brigatinib | |
| Sensitivity (+) | v::ALK | Non-Small Cell Lung Cancer | Brigatinib | |
| Sensitivity (+) | v::ALK | Non-Small Cell Lung Cancer | Brigatinib | |
| Sensitivity (+) | v::ALK | Non-Small Cell Lung Cancer | Brigatinib | |
| Sensitivity (+) | v::ALK | Non-Small Cell Lung Cancer | Brigatinib |